Drug-Induced Liver Injury (DILI) Network Retrospective

Abroad (travel likely)Recruiting

Conditions

Drug Induced Liver Injury

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Southen California, Los Angeles, California, United States

    Contact: Study coordinator (Susan Milstein, RN) · smilstei@usc.edu · 323-442-2699
    Contact: Study coordinator (Neil Kaplowitz, MD) · kaplowit@usc.edu · 323-442-5576
    Contact: Principal Investigator (Andrew Stolz, MD)
  • Indiana University, Indianapolis, Indiana, United States

    Contact: Study coordinator (Jennifer Terrell) · jkramey@iu.edu · 317-278-6266
    Contact: Principal Investigator (Naga P Chalasani, MD)
  • NIH Clinical Site, Bethesda, Maryland, United States

    Contact: Study coordinator (Jaha Norman-Wheeler) · jaha.norman-wheeler@nih.gov · 301-435-6122
    Contact: Study coordinator (Chris Koh, MD) · christopher.koh@nih.gov
  • University of Michigan, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Josefa Kaganove) · kaganovj@med.umich.edu
    Contact: Principal Investigator (Robert J Fontana, MD)
  • Univeristy of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Jacquee Simpson) · Jacqueline_Simpson@med.unc.edu
    Contact: Principal Investigator (Paul B Watkins, MD)
  • Thomas Jefferson, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Katrin Koy) · koykatri@einstein.edu · 215-456-2004
    Contact: Principal Investigator (Dima Halegoua-DeMarzio, MD)
Study leads
  • Huiman X. Barnhart, PhD

    Principal Investigator

    Duke University

  • Robert Fontana, MD

    Study Chair

    University of Michigan